Bo Svensson
Founder at SARomics Biostructures AB
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Sven Anders Mikael Akke | M | 63 |
SARomics Biostructures AB
SARomics Biostructures AB BiotechnologyHealth Technology SARomics Biostructures AB provides protein three-dimensional structure determination and structure-based drug discovery services. The firm develops premium structural biology services. It offers crystallography services, which include crystallization screen and structure determination, nuclear magnetic resonance spectroscopy services, such as ligand binding assays/fragment screening, structure determination, and verification of the structural integrity of target protein, gene-to-structure services, such as protein cloning, expression, purification, and structure determination, kinase structures and kinobits, which include pre-made complexes of kinases with small-molecule fragments to serve as a starting point in a discovery project, structure-based drug discovery services, such as hit identification, hit optimization, and lead generation, gene-to lead services, including a combination of gene-to-structure and structure-based drug discovery, and structure-activity protein optimization services. The company was founded by Björn Ulrik Walse, Sven Anders Mikael Akke, Derek W. Logan, Salam Al-Karadaghi, and Bo Svensson in 2006 and is headquartered in Lund, Sweden. | 18 years |
Björn Ulrik Walse | M | 59 |
SARomics Biostructures AB
SARomics Biostructures AB BiotechnologyHealth Technology SARomics Biostructures AB provides protein three-dimensional structure determination and structure-based drug discovery services. The firm develops premium structural biology services. It offers crystallography services, which include crystallization screen and structure determination, nuclear magnetic resonance spectroscopy services, such as ligand binding assays/fragment screening, structure determination, and verification of the structural integrity of target protein, gene-to-structure services, such as protein cloning, expression, purification, and structure determination, kinase structures and kinobits, which include pre-made complexes of kinases with small-molecule fragments to serve as a starting point in a discovery project, structure-based drug discovery services, such as hit identification, hit optimization, and lead generation, gene-to lead services, including a combination of gene-to-structure and structure-based drug discovery, and structure-activity protein optimization services. The company was founded by Björn Ulrik Walse, Sven Anders Mikael Akke, Derek W. Logan, Salam Al-Karadaghi, and Bo Svensson in 2006 and is headquartered in Lund, Sweden. | 18 years |
Derek W. Logan | M | - |
SARomics Biostructures AB
SARomics Biostructures AB BiotechnologyHealth Technology SARomics Biostructures AB provides protein three-dimensional structure determination and structure-based drug discovery services. The firm develops premium structural biology services. It offers crystallography services, which include crystallization screen and structure determination, nuclear magnetic resonance spectroscopy services, such as ligand binding assays/fragment screening, structure determination, and verification of the structural integrity of target protein, gene-to-structure services, such as protein cloning, expression, purification, and structure determination, kinase structures and kinobits, which include pre-made complexes of kinases with small-molecule fragments to serve as a starting point in a discovery project, structure-based drug discovery services, such as hit identification, hit optimization, and lead generation, gene-to lead services, including a combination of gene-to-structure and structure-based drug discovery, and structure-activity protein optimization services. The company was founded by Björn Ulrik Walse, Sven Anders Mikael Akke, Derek W. Logan, Salam Al-Karadaghi, and Bo Svensson in 2006 and is headquartered in Lund, Sweden. | 18 years |
David Smith | M | 64 | 23 years | |
Salam Al-karadaghi | M | - |
SARomics Biostructures AB
SARomics Biostructures AB BiotechnologyHealth Technology SARomics Biostructures AB provides protein three-dimensional structure determination and structure-based drug discovery services. The firm develops premium structural biology services. It offers crystallography services, which include crystallization screen and structure determination, nuclear magnetic resonance spectroscopy services, such as ligand binding assays/fragment screening, structure determination, and verification of the structural integrity of target protein, gene-to-structure services, such as protein cloning, expression, purification, and structure determination, kinase structures and kinobits, which include pre-made complexes of kinases with small-molecule fragments to serve as a starting point in a discovery project, structure-based drug discovery services, such as hit identification, hit optimization, and lead generation, gene-to lead services, including a combination of gene-to-structure and structure-based drug discovery, and structure-activity protein optimization services. The company was founded by Björn Ulrik Walse, Sven Anders Mikael Akke, Derek W. Logan, Salam Al-Karadaghi, and Bo Svensson in 2006 and is headquartered in Lund, Sweden. | 18 years |
Jens Knobe | M | 63 |
SARomics Biostructures AB
SARomics Biostructures AB BiotechnologyHealth Technology SARomics Biostructures AB provides protein three-dimensional structure determination and structure-based drug discovery services. The firm develops premium structural biology services. It offers crystallography services, which include crystallization screen and structure determination, nuclear magnetic resonance spectroscopy services, such as ligand binding assays/fragment screening, structure determination, and verification of the structural integrity of target protein, gene-to-structure services, such as protein cloning, expression, purification, and structure determination, kinase structures and kinobits, which include pre-made complexes of kinases with small-molecule fragments to serve as a starting point in a discovery project, structure-based drug discovery services, such as hit identification, hit optimization, and lead generation, gene-to lead services, including a combination of gene-to-structure and structure-based drug discovery, and structure-activity protein optimization services. The company was founded by Björn Ulrik Walse, Sven Anders Mikael Akke, Derek W. Logan, Salam Al-Karadaghi, and Bo Svensson in 2006 and is headquartered in Lund, Sweden. | - |
Octavio Díaz de León | M | 57 | 17 years | |
Märta I K Schörling Andreen | F | 40 | 11 years | |
Johanna Asklin | M | 47 |
SARomics Biostructures AB
SARomics Biostructures AB BiotechnologyHealth Technology SARomics Biostructures AB provides protein three-dimensional structure determination and structure-based drug discovery services. The firm develops premium structural biology services. It offers crystallography services, which include crystallization screen and structure determination, nuclear magnetic resonance spectroscopy services, such as ligand binding assays/fragment screening, structure determination, and verification of the structural integrity of target protein, gene-to-structure services, such as protein cloning, expression, purification, and structure determination, kinase structures and kinobits, which include pre-made complexes of kinases with small-molecule fragments to serve as a starting point in a discovery project, structure-based drug discovery services, such as hit identification, hit optimization, and lead generation, gene-to lead services, including a combination of gene-to-structure and structure-based drug discovery, and structure-activity protein optimization services. The company was founded by Björn Ulrik Walse, Sven Anders Mikael Akke, Derek W. Logan, Salam Al-Karadaghi, and Bo Svensson in 2006 and is headquartered in Lund, Sweden. | - |
Sten Randahl Sörensen | M | 65 |
SARomics Biostructures AB
SARomics Biostructures AB BiotechnologyHealth Technology SARomics Biostructures AB provides protein three-dimensional structure determination and structure-based drug discovery services. The firm develops premium structural biology services. It offers crystallography services, which include crystallization screen and structure determination, nuclear magnetic resonance spectroscopy services, such as ligand binding assays/fragment screening, structure determination, and verification of the structural integrity of target protein, gene-to-structure services, such as protein cloning, expression, purification, and structure determination, kinase structures and kinobits, which include pre-made complexes of kinases with small-molecule fragments to serve as a starting point in a discovery project, structure-based drug discovery services, such as hit identification, hit optimization, and lead generation, gene-to lead services, including a combination of gene-to-structure and structure-based drug discovery, and structure-activity protein optimization services. The company was founded by Björn Ulrik Walse, Sven Anders Mikael Akke, Derek W. Logan, Salam Al-Karadaghi, and Bo Svensson in 2006 and is headquartered in Lund, Sweden. | 11 years |
Jan Rene Schou | M | 55 | 13 years |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Fredrik Nilsson | M | 47 | 14 years | |
Peter Korsholm | M | 53 | 2 years | |
Arne Frank | M | 66 | 7 years | |
Anne Mette Olesen | F | 60 | - | |
Fredrik Blomdahl | M | 44 | - | |
Lillie Li Valeur | M | 54 | 6 years | |
Jean-Marc Rotsaert | M | 54 | 3 years | |
Edmond Borit | M | 55 | - | |
Harald Sauthoff | M | 69 | - | |
Märit Beckeman | M | 81 | - | |
Ulrik Svensson | M | 63 | 10 years | |
Renald MacKintosh | M | 73 | - | |
Terrence W. Thomas | M | 62 | 5 years | |
Anders Daniel Davidsson | M | 54 | - | |
Ted Jörgensen | M | 69 | - | |
Roland Mårtensson | M | 58 | - | |
Rune Tommy Andersson | M | 76 | - | |
Christer Svantesson | M | 73 | - | |
Ulf Friberg | M | 70 | - | |
Karsten Nielsen | M | 61 | - | |
Jerker Gustav Hartwall | M | 54 | - | |
John Allen Goodwin | M | 80 | 7 years | |
Carl Bek-Nielsen | M | 51 | 8 years | |
Martin Lauge Bek-Nielsen | M | 49 | 8 years | |
Torben Friis-Lange | M | 61 | - | |
Melker Yngve Georg Schörling | M | 77 | 12 years | |
Annika Westerlund | F | 68 | - | |
Leif Håkansson | M | 67 | 17 years | |
Jean-Marc Rotseart | M | 55 | 3 years | |
Carl Johan Kördel | M | 62 |
SARomics Biostructures AB
SARomics Biostructures AB BiotechnologyHealth Technology SARomics Biostructures AB provides protein three-dimensional structure determination and structure-based drug discovery services. The firm develops premium structural biology services. It offers crystallography services, which include crystallization screen and structure determination, nuclear magnetic resonance spectroscopy services, such as ligand binding assays/fragment screening, structure determination, and verification of the structural integrity of target protein, gene-to-structure services, such as protein cloning, expression, purification, and structure determination, kinase structures and kinobits, which include pre-made complexes of kinases with small-molecule fragments to serve as a starting point in a discovery project, structure-based drug discovery services, such as hit identification, hit optimization, and lead generation, gene-to lead services, including a combination of gene-to-structure and structure-based drug discovery, and structure-activity protein optimization services. The company was founded by Björn Ulrik Walse, Sven Anders Mikael Akke, Derek W. Logan, Salam Al-Karadaghi, and Bo Svensson in 2006 and is headquartered in Lund, Sweden. | 5 years |
Ebbe Simonsen | M | 84 | 4 years | |
Jørgen Balle | M | 59 | 3 years |
Statistics
Country | Connections | % of total |
---|---|---|
Sweden | 43 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Bo Svensson
- Personal Network